ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
7
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,506
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
The first biosimilar epoetin: but how similar is it?
Author(s):
Huub Schellekens
Publication date:
2007-12-31
Journal:
Clinical journal of the American Society of Nephrology : CJASN
Keywords:
Anemia
,
drug therapy
,
Biological Products
,
pharmacokinetics
,
therapeutic use
,
Erythropoietin
,
European Union
,
Hematinics
,
Humans
,
Recombinant Proteins
,
Therapeutic Equivalency
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Acta Materia Medica
Author and article information
Journal
PubMed ID::
18057303
DOI::
10.2215/CJN.04251007
ScienceOpen disciplines:
Chemistry
Keywords:
Anemia
,
drug therapy
,
Biological Products
,
pharmacokinetics
,
therapeutic use
,
Erythropoietin
,
European Union
,
Hematinics
,
Humans
,
Recombinant Proteins
,
Therapeutic Equivalency
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Anemia
,
drug therapy
,
Biological Products
,
pharmacokinetics
,
therapeutic use
,
Erythropoietin
,
European Union
,
Hematinics
,
Humans
,
Recombinant Proteins
,
Therapeutic Equivalency
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,506
Biological Characterization of SB3, a Trastuzumab Biosimilar, and the Influence of Changes in Reference Product Characteristics on the Similarity Assessment
Authors:
Jae Lee
,
Kyungyeol Paek
,
Jae Moon
…
Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product
Authors:
Neungseon Seo
,
Zhe Huang
,
Scott Kuhns
…
Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists
Authors:
Paulo Urbano
,
Vanete Thomaz Soccol
,
Valderilio Azevedo
See all similar
Cited by
5
Biosimilar therapeutics—what do we need to consider?
Authors:
Huub Schellekens
Biosimilar agents in oncology/haematology: from approval to practice
Authors:
Dietger Niederwieser
,
Stephan Schmitz
Clinical trials for authorized biosimilars in the European Union: a systematic review
Authors:
Johanna Mielke
,
Bernd Jilma
,
Franz Koenig
…
See all cited by